OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VIKR56

Vikas Lifecare Ltd

Commodity ChemicalsVerified

Vikas Lifecare Ltd has a capital structure with a debt-to-equity ratio of 0.14, indicating a relatively low level of leverage compared to industry norms. However, the company's liquidity position is weak, with only INR 1,000 in cash and equivalents and a negative operating cash flow of INR -2.22 billion, which raises concerns about its ability to meet short-term obligations. Profitability is a major concern, as the company reported a net loss of INR -106.14 million and an operating loss of INR -69.42 million. The return on equity (ROE) is -2.00%, and the return on assets (ROA) is -1.46%, both significantly below the industry median for Commodity Chemicals. These metrics suggest the company is underperforming in terms of generating returns for shareholders and utilizing its assets efficiently. The company operates across multiple segments, including Trading & Manufacturing Division - Agro, Trading & Manufacturing Division - Polymers, Trading Division - Infrastructure, and Trading Division - Gas Meter, as well as a B2C segment with FMCG products. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each division. Growth appears to be a challenge, as the company is currently reporting a net loss and negative operating cash flow. The outlook for the current fiscal year is uncertain, with no clear indication of improvement in profitability or cash flow generation. The company's capital expenditure of INR -127 million suggests some investment in operations, but it is unclear whether this will lead to meaningful growth in the near term. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a red flag for liquidity. However, the low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders. Recent events, including the 2023 annual report, highlight the company's financial struggles, with a significant operating and net loss. The report also notes the company's exposure to global supply chain disruptions and raw material price volatility, which could further impact its financial performance.

30-day price · VIKR+0.27 (+21.8%)
Low$1.07High$1.70Close$1.51As of17 May, 00:00 UTC
Profile
CompanyVikas Lifecare Ltd
TickerVIKR.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Vikas Lifecare Ltd is a provider of high-end specialty chemicals, manufacturing and trading polymer and rubber compounds, specialty additives, and up-cycled compounds from industrial and post-consumer waste materials, while also operating in the B2C segment with FMCG and agro products.

Classification. Vikas Lifecare Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Vikas Lifecare Ltd has a capital structure with a debt-to-equity ratio of 0.14, indicating a relatively low level of leverage compared to industry norms. However, the company's liquidity position is weak, with only INR 1,000 in cash and equivalents and a negative operating cash flow of INR -2.22 billion, which raises concerns about its ability to meet short-term obligations. Profitability is a major concern, as the company reported a net loss of INR -106.14 million and an operating loss of INR -69.42 million. The return on equity (ROE) is -2.00%, and the return on assets (ROA) is -1.46%, both significantly below the industry median for Commodity Chemicals. These metrics suggest the company is underperforming in terms of generating returns for shareholders and utilizing its assets efficiently. The company operates across multiple segments, including Trading & Manufacturing Division - Agro, Trading & Manufacturing Division - Polymers, Trading Division - Infrastructure, and Trading Division - Gas Meter, as well as a B2C segment with FMCG products. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each division. Growth appears to be a challenge, as the company is currently reporting a net loss and negative operating cash flow. The outlook for the current fiscal year is uncertain, with no clear indication of improvement in profitability or cash flow generation. The company's capital expenditure of INR -127 million suggests some investment in operations, but it is unclear whether this will lead to meaningful growth in the near term. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a red flag for liquidity. However, the low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders. Recent events, including the 2023 annual report, highlight the company's financial struggles, with a significant operating and net loss. The report also notes the company's exposure to global supply chain disruptions and raw material price volatility, which could further impact its financial performance.
Key takeaways
  • Vikas Lifecare Ltd is experiencing significant financial distress, with a net loss and negative operating cash flow.
  • The company's capital structure is relatively low in leverage, but its liquidity position is weak.
  • Profitability metrics are far below industry medians, indicating poor performance in generating returns.
  • The company operates in multiple segments, but the lack of segment-specific financial data limits the ability to assess performance.
  • The risk assessment highlights medium liquidity risk and low dilution risk, with a negative net cash position being a key concern.
  • Recent events and disclosures suggest ongoing challenges with profitability and cash flow generation.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$4.80B
Gross profit$150.3M
Operating income-$69.4M
Net income-$106.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$2.22B
CapEx-$127.0M
Free cash flow-$169.9M
Total assets$7.29B
Total liabilities$1.97B
Total equity$5.32B
Cash & equivalents$1.0k
Long-term debt$767.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.32B
Net cash-$767.0M
Current ratio1.8
Debt/Equity0.1
ROA-1.5%
ROE-2.0%
Cash conversion20.9%
CapEx/Revenue-2.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricVIKRActivity
Op margin-1.4%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-2.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin3.1%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity14.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 18:37 UTC#96806c34
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 13:23 UTCJob: b3c36beb